COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
DelveInsight’s “Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Becker Muscular Dystrophy, historical and forecasted epidemiology as well as the Becker Muscular Dystrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Becker Muscular Dystrophy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Becker Muscular Dystrophy Market Forecast
Some of the key facts of the Becker Muscular Dystrophy Market Report:
• The Becker Muscular Dystrophy market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to the American Association of Neuromuscular & Electrodiagnostic Medicine, approximately three out of every 100,000 people gets affected by BMD. Additionally, few BMD patients can live a normal lifespan, however most die sometime after the age of 40
• In about two thirds of cases, an affected male inherits the mutation from his mother who carries a mutated copy of the DMD gene. The other third of cases probably result from new mutations in the gene
• Through several studies, it can be estimated that the occurrence of BMD varies from one per 18,000 to one per 31,000 male births
• According to the Genetic and Rare Diseases Information Center, the prevalence of BMD is estimated to be between 17–27 cases per million people
• According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of Duchenne and Becker muscular dystrophy (DBMD) was one in every 7,250 males aged 5–24 years
• Key Becker Muscular Dystrophy Companies: ReveraGen Biopharma, Italfarmaco, Italfarmaco, PTC Therapeutics, RSPR Pharma AB, Hoffmann-La Roche, NS Pharma, Inc., ARMGO Pharma Inc, Edgewise Therapeutics Inc, Epirium Bio Inc, Italfarmaco SpA, Milo Biotechnology LLC, PhaseBio Pharmaceuticals Inc, Santhera Pharmaceuticals Holding AG, Sarcomed AB, Scholar Rock Inc, Stealth BioTherapeutics Corp, Tivorsan Pharmaceuticals Inc, and others
• Key Becker Muscular Dystrophy Therapies: Vamorolone, Givinostat, (-)-Epicatechin, EDG-5506, givinostat, Ataluren, CRD007, RO7239361, NS-065/NCNP-01, and others
• The Becker Muscular Dystrophy epidemiology based on gender analyzed that Becker Muscular Dystrophy affects males more than females
• The Becker Muscular Dystrophy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Becker Muscular Dystrophy pipeline products will significantly revolutionize the Becker Muscular Dystrophy market dynamics.
Becker Muscular Dystrophy Overview
Becker Muscular Dystrophy (BMD) is an inherited muscle structure disorder that results in progressive deterioration of limbs, cardiac and skeletal muscles. However, the involuntary muscles are not affected. BMD is milder version of Duchenne Muscular Dystrophy (DMD). BMD usually begins in the teens or early adulthood, and the course is slower and far less predictable than that of DMD.
Get a Free sample for the Becker Muscular Dystrophy Market Report
Becker Muscular Dystrophy Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Becker Muscular Dystrophy Epidemiology Segmentation:
The Becker Muscular Dystrophy market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
• Total Prevalence of Becker Muscular Dystrophy
• Prevalent Cases of Becker Muscular Dystrophy by severity
• Gender-specific Prevalence of Becker Muscular Dystrophy
• Diagnosed Cases of Episodic and Chronic Becker Muscular Dystrophy
Download the report to understand which factors are driving Becker Muscular Dystrophy epidemiology trends @ Becker Muscular Dystrophy Epidemiology Forecast
Becker Muscular Dystrophy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Becker Muscular Dystrophy market or expected to get launched during the study period. The analysis covers Becker Muscular Dystrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Becker Muscular Dystrophy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Becker Muscular Dystrophy Therapies and Key Companies
• Vamorolone: ReveraGen Biopharma
• Givinostat: Italfarmaco
• (-)-Epicatechin: Epirium Bio
• EDG-5506: Edgewise Therapeutics
• givinostat: Italfarmaco
• Ataluren: PTC Therapeutics
• CRD007: RSPR Pharma AB
• RO7239361: Hoffmann-La Roche
• NS-065/NCNP-01: NS Pharma, Inc.
Discover more about therapies set to grab major Becker Muscular Dystrophy market share @ Becker Muscular Dystrophy Treatment Market
Becker Muscular Dystrophy Market Strengths
• Research and development are ongoing, ranging from the preclinical stage to late stage to boon the market of BMD in future
• Several associations such as Muscular Dystrophy Association (MDA), National Organization for Rare Disorders (NORD), etc. are rigorously involved in providing clarity for BMD Paradigm
Becker Muscular Dystrophy Market Unmet Needs
• Challenge in recognition of condition
• Development of novel therapies
• Limited availability in services
• Poor disease understanding
• Development of effective treatment
Scope of the Becker Muscular Dystrophy Market Report
• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Becker Muscular Dystrophy Companies: ReveraGen Biopharma, Italfarmaco, Italfarmaco, PTC Therapeutics, RSPR Pharma AB, Hoffmann-La Roche, NS Pharma, Inc., ARMGO Pharma Inc, Edgewise Therapeutics Inc, Epirium Bio Inc, Italfarmaco SpA, Milo Biotechnology LLC, PhaseBio Pharmaceuticals Inc, Santhera Pharmaceuticals Holding AG, Sarcomed AB, Scholar Rock Inc, Stealth BioTherapeutics Corp, Tivorsan Pharmaceuticals Inc, and others
• Key Becker Muscular Dystrophy Therapies: Vamorolone, Givinostat, (-)-Epicatechin, EDG-5506, givinostat, Ataluren, CRD007, RO7239361, NS-065/NCNP-01, and others
• Becker Muscular Dystrophy Therapeutic Assessment: Becker Muscular Dystrophy current marketed and Becker Muscular Dystrophy emerging therapies
• Becker Muscular Dystrophy Market Dynamics: Becker Muscular Dystrophy market drivers and Becker Muscular Dystrophy market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Becker Muscular Dystrophy Unmet Needs, KOL’s views, Analyst’s views, Becker Muscular Dystrophy Market Access and Reimbursement
To know more about Becker Muscular Dystrophy companies working in the treatment market, visit @ Becker Muscular Dystrophy Clinical Trials and Therapeutic Assessment
Table of Contents
1. Becker Muscular Dystrophy Market Report Introduction
2. Executive Summary for Becker Muscular Dystrophy
3. SWOT analysis of Becker Muscular Dystrophy
4. Becker Muscular Dystrophy Patient Share (%) Overview at a Glance
5. Becker Muscular Dystrophy Market Overview at a Glance
6. Becker Muscular Dystrophy Disease Background and Overview
7. Becker Muscular Dystrophy Epidemiology and Patient Population
8. Country-Specific Patient Population of Becker Muscular Dystrophy
9. Becker Muscular Dystrophy Current Treatment and Medical Practices
10. Becker Muscular Dystrophy Unmet Needs
11. Becker Muscular Dystrophy Emerging Therapies
12. Becker Muscular Dystrophy Market Outlook
13. Country-Wise Becker Muscular Dystrophy Market Analysis (2019–2032)
14. Becker Muscular Dystrophy Market Access and Reimbursement of Therapies
15. Becker Muscular Dystrophy Market Drivers
16. Becker Muscular Dystrophy Market Barriers
17. Becker Muscular Dystrophy Appendix
18. Becker Muscular Dystrophy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports by DelveInsight-
scedosporium infection market | autoimmune pulmonary alveolar proteinosis market | rosai-dorfman disease market | sandhoff disease market | b-cell chronic lymphocytic leukemia market | bladder cancer market | trichomoniasis market | bile duct cancer market | resorbable vascular scaffold market | salivary gland infection market | ischemic stroke market | paget’s disease market | ventricular assist devices market | vascular stents market | vascular graft devices market | bladder scanners market | b-cell non-hodgkin lymphoma market | basal cell carcinoma market | birch allergy market | vein illumination devices market
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting